Bio:

John Paul is a research associate on the Assay Development team where he works on the characterization and quality control of the gene-edited stem cell lines produced by the Cell Science division. He previously worked on therapies for rare muscle and repeat expansion disease in the Rare Diseases Research Unit at Pfizer in Cambridge, Massachusetts. John Paul graduated from Northeastern University in Boston with a degree in Biochemistry.